News | Artificial Intelligence

At the American Heart Association’s (AHA) Scientific Sessions 2018, Nov. 10-12 in Chicago, Eko presented a clinical study abstract revealing the first murmur detection algorithm to outperform the majority of participating cardiologists. Entitled “Artificial Intelligence Detects Pediatric Heart Murmurs With Cardiologist-Level Accuracy,” the study demonstrates the power of machine learning and artificial intelligence (AI) to enhance cardiac care.

Home November 11, 2018
Home
News | Wearables

Wearable cardiac biosensor developer Cardiac Insight Inc. has partnered with VivoSense, specializing in integration and specialized analysis of wearable sensor data for research and clinical trials. Together, both companies will deliver enhanced research analytics to help VivoSense expand the use of wearable biosensors for pharmaceutical clinical trials and other healthcare applications.

Home November 09, 2018
Home
News | Peripheral Artery Disease (PAD)

November 9, 2018 — VentureMed Group Inc. announced the initiation of a new study to determine if the Flex Dynamic ...

Home November 09, 2018
Home
News | EP Lab

The American College of Cardiology (ACC), the American Heart Association (AHA) and the Heart Rhythm Society (HRS) released a guideline for the evaluation and treatment of patients with bradycardia, or a slow heartbeat, and cardiac conduction disorders.

Home November 09, 2018
Home
News | Peripheral Artery Disease (PAD)

The Lutonix Drug-Coated Balloon (DCB) showed statistically significant safety equivalence with a standard percutaneous transluminal angioplasty (PTA) catheter for the treatment of narrowed or obstructed arteries below the knee in recent trial results. The data were presented at the Vascular Interventional Advances (VIVA) 2018 annual conference, Nov. 5-8 in Las Vegas.

Home November 07, 2018
Home
Videos | Hypertension

Kim Allan Williams, Sr., M.D., chief of the Division of Cardiology and the James B. Herrick Professor at Rush University ...

Home November 07, 2018
Home
News | Heart Failure

November 6, 2018 – Initial results from the real-world EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) ...

Home November 07, 2018
Home
Sponsored Content | Videos | Cath Lab

In 2009, the GuideLiner Catheter revolutionized the concept of guide extension, creating new possibilities in ...

Home November 07, 2018
Home
News | Heart Valve Technology

4Tech Inc. initiated its U.S. Early Feasibility Study of the TriCinich Coil System following U.S. Food and Drug Administration (FDA) approval, with the first two implantations at Piedmont Heart Hospital in Atlanta. The implantations were conducted by Christopher Meduri, M.D., Vivek Rajagopal, M.D., and Mani Vannan, M.D. The study will evaluate the TriCinch Coil System in 15 patients across seven centers in the U.S.

Home November 06, 2018
Home
Technology | Mobile C-Arms

Siemens Healthineers announced the U.S. Food and Drug Administration (FDA) clearance of the Cios Spin, a new mobile C-arm that delivers precise 3-D images for intraoperative quality assurance.

Home November 06, 2018
Home
News | Intra-Aortic Balloon Pumps (IABP)

November 5, 2018 — The U.S. Food and Drug Administration (FDA) is evaluating recent reports of Getinge's Maquet ...

Home November 05, 2018
Home
Technology | Vascular Closure Devices

November 2, 2018 — Cordis, a Cardinal Health company, today announced the U.S. launch of Mynx Control Vascular Closure ...

Home November 05, 2018
Home
News | Heart Valve Technology

Hospitals that routinely perform a heart valve replacement procedure requiring open heart surgery are more likely to adopt a newer, less invasive technique, according to a new study, published Oct. 31 in JAMA Cardiology from Weill Cornell Medicine. When hospitals have a high caseload of both, they are likely to achieve the best patient outcomes for those who undergo the newer procedure.

Home November 02, 2018
Home
News | Heart Failure

In a new study, acute heart failure patients who received individualized treatment by blood volume measurement with the BVA-100 blood volume analyzer showed statistically significantly reduced 30-day readmission and 30-day and one-year mortality rates. The study, published in the Journal of the American College of Cardiology - Heart Failure,1 compared the experimental group to propensity-matched controls.

Home November 02, 2018
Home
Technology | Wearables

Digital health company Planet Intelligent recently launched the ExMedicus Smartwatch, what it calls the world’s first health smartwatch with biometric technology that monitors overall health, heart health and physical wellness.

Home November 02, 2018
Home
Subscribe Now